Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 9 December 2008, doi:10.1136/bmj.a2467
Cite this as: BMJ 2008;337:a2467
Jane A Driver, instructor of medicine1, Luc Djoussé, assistant professor of medicine1, Giancarlo Logroscino, associate professor of neurology2, J Michael Gaziano, associate professor of medicine1,3,4, Tobias Kurth, assistant professor of medicine and epidemiology1,3,5
1 Division of Aging, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215, USA, 2 Department of Neurology and Psychiatry, School of Medicine, University of Bari, Italy, 3 Preventive Medicine, Department of Medicine, Brigham and Womens Hospital, 4 Massachusetts Veterans Epidemiology Research Information Center, VA Boston Healthcare System, Boston, MA, 5 Department of Epidemiology, Harvard School of Public Health, Boston, MA
Correspondence to: J A Driver jdriver{at}partners.org
Design Prospective cohort study.
Setting United States.
Participants 22 048 male doctors aged 40-84 who were free of major disease in 1982.
Main outcome measures Incidence and remaining lifetime risk of major cardiovascular disease (myocardial infarction, stroke, and death from cardiovascular disease) and cancer.
Results 3252 major cardiovascular events and 5400 incident cancers were confirmed over 23 years of follow-up. The incidence of major cardiovascular disease continued to increase to age 100. Beginning at age 80, however, major cardiovascular disease was more likely to be diagnosed at death. The incidence of cancer peaked in those aged 80-89 and then declined. Cancers detected by screening accounted for most of the decline, whereas most cancers for which there was no screening continued to increase to age 100. Unadjusted cumulative incidence overestimated the risk of cardiovascular disease by 16% and cancer by 8.5%. The remaining lifetime risk of cancer at age 40 was 45.1% (95% confidence interval 43.8% to 46.3%) and at age 90 was 9.6% (7.2% to 11.9%). The remaining lifetime risk of major cardiovascular disease at age 40 was 34.8% (33.1% to 36.5%) and at age 90 was 16.7% (12.9% to 20.6%).
Conclusions In this prospective cohort of men, the incidence of new cardiovascular disease continued to increase after age 80 but was most often diagnosed at death. The decrease in incidence of cancer late in life seemed largely due to a decline in cancers usually detected by screening. These findings suggest that people aged 80 and older have a substantial amount of undiagnosed disease. The remaining lifetime risk of both diseases approached a plateau in the 10th decade. This may be due to decreased detection of disease and reporting of symptoms and increased resistance to disease in those who survive to old age. Accurate estimates of disease risk in an aging population require adjustment for competing risks of mortality.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses